[1. A. M. Siouffi and R. Phan-Tan-Luu, Optimization methods in chromatography and capillary electrophoresis, J. Chromatogr. A 892 (2000) 75-106; DOI: 10.1016/S0021-9673(00)00247-8.10.1016/S0021-9673(00)00247-8]Search in Google Scholar
[2. A. Malenović, Y. Dotsikas, M. Mašković, B. Jančić Stojanović, D. Ivanović and M. Medenica, Desirability-based optimization and its sensitivity analysis for the perindopril and its impurities analysis in a microemulsion LC system, Microchem. J. 99 (2011) 454-460; DOI: 10.1016/j.microc. 2011.06.022.]Search in Google Scholar
[3. M. A. Bezerra, R. E. Santelli, E. P. Oliveira, L. S. Villar and L. A. Escaleira, Response surface methodology (RSM) as a tool for optimization in analytical chemistry, Talanta 76 (2008) 965-977; DOI: 10.1016/j.talanta.2008.05.019.10.1016/j.talanta.2008.05.019]Search in Google Scholar
[4. S. L. C. Ferreira, W. N. L. Dos Santos, C. M. Quintella, B. B. Neto and J. M. Bosque-Sendra, Doehlert matrix: A chemometric tool for analytical chemistry-Review, Talanta 63 (2004) 1061-1067; DOI: 10.1016/j.talanta.2004.01.015.10.1016/j.talanta.2004.01.015]Search in Google Scholar
[5. Y. Vander Heyden and D. L. Massart, Review of the Use of Robustness and Ruggedness in AnalyticalChemistry, in Robustness of Analytical Chemical Methods and Pharmaceutical Technological Products (Eds. M. W. B. Hendriks, J. H. De Boer and A. K. Smilde), Elsevier, Amsterdam 1996.10.1016/S0922-3487(96)80016-5]Search in Google Scholar
[6. Y. VanderHeyden, A. Nijhuis, J. Smeyers-Verbeke, B. G. M. Vandeginste and D. L. Massart, Guidance for robustness/ruggedness tests in method validation, J. Pharm. Biomed. Anal. 24 (2001) 723-753; DOI: 10.1016/S0731-7085(00)00529-X.10.1016/S0731-7085(00)00529-X]Search in Google Scholar
[7. M. Mašković, B. Jančić-Stojanović, A. Malenović, D. Ivanović and M. Medenica, Assessment of liquid chromatographic method robustness by use of Plackett-Burman design, Acta Chromatogr. 22 (2010) 281-296; DOI: 10.1556/AChrom.22.2010.2.10.10.1556/AChrom.22.2010.2.10]Search in Google Scholar
[8. T. Rakić, A. Malenović, B. Jančić-Stojanović, D. Ivanović and M. Medenica, Avoiding the false negative results in LC method robustness testing by modifications of the algorithm of Dong and dummy factor effects approach, Chromatographia 75 (2012) 397-401; DOI: 10.1007/s10337-012-2196-6.10.1007/s10337-012-2196-6]Search in Google Scholar
[9. European Pharmacopeia, 7th ed., Council of Europe, Strasbourg 2011, pp. 2297-2299.]Search in Google Scholar
[10. M. Dumarey, R. Sneyers, W. Janssens, I. Somers and Y. Vander Heyden, Drug impurity profiling: Method optimization on dissimilar chromatographic systems: Part I: pH optimization of the aqueous phase, Anal. Chim. Acta 656 (2009) 85-92; DOI: 10.1016/j.aca.2009.10.013.10.1016/j.aca.2009.10.013]Search in Google Scholar
[11. D. Compas, D. J. Touw and P. N. F. C. de Goede, Rapid method for the analysis of itraconazole and hydroxyitraconazole in serum by high-performance liquid chromatography, J. Chromatogr. B 687 (1996) 453-456; DOI: 10.1016/S0378-4347(96)00245-9.10.1016/S0378-4347(96)00245-9]Search in Google Scholar
[12. C. H. W. Koks, R. W. Sparidans, G. Lucassen, K. M. L. Crommentuyn and J. H. Beijnen, Selective high-performance liquid chromatographic assay for itraconazole and hydroxyitraconazole in plasma from human immunodeficiency virus-infected patients, J. Chromatogr. B 767 (2002) 103-110; DOI: 10.1016/S0378-4347(01)00550-3.10.1016/S0378-4347(01)00550-3]Search in Google Scholar
[13. V. Srivatsan, A. K. Dasgupta, P. Kale, R. R. Datla, D. Soni, M. Patel, R. Patel and C. Mavadhiya, Simultaneous determination of itraconazole and hydroxyitraconazole in human plasma by high- -performance liquid chromatography, J. Chromatogr. A 1031 (2004) 307-313; DOI: 10.1016/j.chroma. 2003.11.061.]Search in Google Scholar
[14. T. Uno, M. Shimizu, K. Sugawara and T. Tateishi, Sensitive determination of itraconazole and its active metabolite in human plasma by column-switching high-performance liquid chromatography with ultraviolet detection, Ther. Drug Monit. 28 (2006) 526-531; DOI: 10.1097/00007691-200608000-00007.10.1097/00007691-200608000-00007]Search in Google Scholar
[15. P. Kubalec and E. Brandšteterová, Column-switching chromatographic determination of itraconazole and its metabolite hydroxy-itraconazole in human serum, Pharmazie 56 (2001) 397-400.]Search in Google Scholar
[16. W. C. Young, D. Nam, H. K. Kyoung, W. H. Kyung, H. H. In, K. C. Byung, M. Yoon and J. Lee, High-performance liquid chromatographic-tandem mass spectrometric determination of itraconazole in human plasma for bioavailability and bioequivalence studies, Bull. Korean Chem. Soc.27 (2006) 291-294; DOI: 10.5012/bkcs.2006.27.2.291.10.5012/bkcs.2006.27.2.291]Search in Google Scholar
[17. L. Bai, M. M. Li, C. J. Zhao and T. T. Ma, Determination of itraconazole in human plasma by HPLC and studies of bioequivalence, Chinese Pharmaceut. J. 43 (2008) 1272-1274.]Search in Google Scholar
[18. J.W.Wong, U. R. Nisar and K. H. Yuen, Liquid chromatographic method for the determination of plasma itraconazole and its hydroxy metabolite in pharmacokinetic/bioavailability studies, J. Chromatogr. B 798 (2003) 355-360; DOI: 10.1016/j.jchromb.2003.09.059.10.1016/j.jchromb.2003.09.059]Search in Google Scholar
[19. L. Baietto, A. D’Avolio, G. Ventimiglia, F. G. De Rosa, M. Siccardi, M. Simiele, M. Sciandra and G. Di Perri, Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma, Antimicrob. Agents Chemother. 54 (2010) 3408-3413; DOI: 10.1128/AAC.01807-09. 10.1128/AAC.01807-09]Search in Google Scholar
[20. W. Chen, B. Gu, H. Wang, J. Pan,W. Lu and H. Hou. Development and evaluation of novel itraconazole- loaded intravenous nanoparticles, Int. J. Pharm. 362 (2008) 133-140; DOI: 10.1016/j.ijpharm. 2008.05.039.]Search in Google Scholar
[21. L. Gagliardi, D. De Orsi, P. Chimenti, R. Porra and D. Tonelli, HPLC determiantion of imidazole antimycotics in antidandruff cosmetic products, Anal. Sci. 19 (2003) 11951197; DOI: 10.2116/analsci. 19.1195.]Search in Google Scholar
[22. S. L. C. Ferreira, R. E. Bruns, E. G. P. da Silva, W. N. L. dos Santos, C. M. Quintella, J. M. Davis, J. B. de Andrade, M. C. Breitkreitz, I. C. S. F. Jardim and B. B. Neto, Statistical designs and response surface techniques for the optimization of chromatographic systems, J. Chromatogr. A 1158 (2007) 2-14; DOI: 10.1016/j.chroma.2007.03.051.10.1016/j.chroma.2007.03.051]Search in Google Scholar
[23. R. L. Mason, R. F. Gunst and J. L. Hess, Statistical Design and Analysis of Experiments With Applicationto Engineering and Science, 2nd ed., Hoboken, New York 2003.10.1002/0471458503]Search in Google Scholar
[24. G. C. Carle, Determination of chromatographic resolution for peaks of vast concentration differences, Anal. Chem. 44 (1972) 1905-1906.10.1021/ac60319a030]Search in Google Scholar
[25. R. E. Kaiser, Gas Chromatographie, Portig, Leipzig 1960, p. 33.10.1007/978-1-4684-8291-1_2]Search in Google Scholar
[26. F. Dong, On the identification of active contrasts in unreplicated fractional factorials, Stat. Sinica3 (1993) 209-217.]Search in Google Scholar
[27. J. B. Crowther, Validation of Pharmaceutical Test Methods, in Handbook of Modern PharmaceuticalAnalysis (Eds. S. Ahuja and S. Scypinski), Academic Press, New York 2001, pp. 415-443. 10.1016/S0149-6395(01)80014-3]Search in Google Scholar